Evaluate the Safety, Tolerability, and Efficacy of UthPeak NMNH (Reduced Nicotinamide Mononucleotide) in Healthy Adult Participants
Clinical trial NCT06889740 · COMPLETED
Trial details
- NCT number
- NCT06889740
- Sponsor
- EffePharm LTD
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-08
- Primary completion
- 2024-12-08
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.